Buy-Side Mandate: Medical Billing / RCM Platform ($500k - $1.5M EBITDA)
January 14, 2026
by a searcher from Arizona State University - W. P. Carey School of Business in Miami, FL, USA
I am an Independent Sponsor executing a roll-up strategy in the Medical Billing / Revenue Cycle Management (RCM) space. We are looking to acquire a platform asset immediately, with a committed capital structure in place to close quickly.
Investment Criteria:
Sector: Medical Billing / RCM (Specialty agnostic, but prefer Cardio, Ortho, or Behavioral Health).
Financials: $500k – $1.5M EBITDA (Platform); $200k+ (Add-ons).
Geography: Nationwide (Remote-first preferred).
Model: Recurring revenue, low customer concentration (<15%).
Deal Structure: We are modeled for a standard leveraged buyout (Senior Debt + Seller Financing). We are SBA-eligible if the asset requires it. We are comfortable with complex deal structures and can move to LOI within 7-14 days of data room access.
For Intermediaries: Buy-side fees are protected. If you have a pocket listing that fits this box, please DM me. We provide feedback on teasers within 24 hours.
from The Johns Hopkins University in Gainesville, FL, USA